查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933861

醫用二尖瓣環狀成形術環市場（按器械類型、手術類型、材料類型、病患年齡層和最終用戶管道分類）－全球預測，2026-2032年

Medical Mitral Annuloplasty Ring Market by Device Type, Procedure Type, Material Type, Patient Age Group, End User Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年，醫用二尖瓣環狀成形術環市場價值為 3.2345 億美元，預計到 2026 年將成長至 3.5232 億美元，到 2032 年將達到 5.8732 億美元，複合年成長率為 8.89%。

主要市場統計數據
基準年 2025 3.2345億美元
預計年份：2026年 3.5232億美元
預測年份：2032年 5.8732億美元
複合年成長率 (%) 8.89%

簡潔扼要、權威詳盡地介紹了二尖瓣環狀成形術環在現代心臟修復中不斷演變的作用和戰略決策。

二尖瓣環狀成形術環在現代瓣膜修復中發揮核心作用，影響不同病患群體的手術選擇、器械創新和臨床療效。近年來，瓣環設計、材料科學和植入技術的不斷改進，為外科醫生和心臟病專家拓展了治療選擇。隨著臨床適宜時修復手術逐漸取代置換手術，人們對瓣環形態、順應性和組織相互作用的關注度日益提高，促使製造商和臨床團隊重新評估其器械選擇框架。

持續的設計創新、材料進步、程序變更和監管要求如何重新定義二尖瓣環環狀成形術環的開發和應用

二尖瓣瓣環成形術段正經歷多項變革，這些變革正在重塑臨床實踐和產業發展方向。首先，器械設計的演變正超越剛性與軟性結構的二元選擇，轉向旨在平衡瓣環重塑和生理運動的混合解決方案。半剛性和鞍形剛性器材的創新，透過為不同病理情況提供客製化的動態特性，正在改變術中決策。

分析 2025 年美國關稅變化如何促使設備製造商加強供應鏈韌性、轉變採購方式並進行商業性。

2025年實施的關稅政策變更給整個醫療設備供應鏈帶來了複雜的挑戰，並促使其進行策略性調整，這與二尖瓣環環狀成形術環的供應和價格波動密切相關。具體而言，某些零件和原料進口關稅的提高增加了到岸成本，迫使製造商重新評估其籌資策略和庫存管理政策。為因應這項變化，各公司加快了近岸外包的步伐，並使其供應商網路多元化，以分散風險，同時確保器械品質並符合監管要求。

詳細的分析闡述了設備設計、手術流程、終端用戶環境、材料以及患者年齡如何影響臨床和商業策略。

細緻的市場細分框架揭示了不同器械類型、手術類型、終端用戶管道、材料選擇和患者群體特徵所帶來的獨特臨床和商業性影響。按器械類型分類的市場特徵包括：軟性環（包括二尖瓣和單尖瓣設計）；剛性環（圓形和鞍形幾何形狀）；以及半剛性環（有全封閉式和開放式設計）。每種類型都針對不同的二尖瓣病變和手術方法，因此需要有針對性的證據資料和外科醫生培訓計劃。

區域比較分析突顯了美洲、歐洲、中東、非洲和亞太地區在臨床應用、法規結構和支付方趨勢方面的差異。

區域趨勢持續影響美洲、歐洲、中東和非洲以及亞太地區的臨床實踐模式、監管要求和商業化策略。在美洲，高手術量、二尖瓣修復手術轉換率高以及成熟的學術中心網路推動了創新瓣環結構和材料的早期應用。同時，日益複雜的採購流程和支付方日益嚴格的審查迫使製造商更加重視產品價值和長期療效數據。在這段過渡時期，美洲市場往往是臨床證據產生的風向標，影響其他地區的應用。

對環狀成形術環領域的競爭格局、創新管道和夥伴關係模式進行策略概述，以推動差異化和臨床應用。

二尖瓣環狀成形術環環領域的競爭格局是由成熟的醫療技術公司、專業器材創新者、專業契約製造和專注於臨床的新興企業之間的相互作用所塑造的。市場領導通常利用其廣泛的心血管產品組合、全球監管地位和長期建立的臨床關係來贏得外科醫生的青睞和醫療機構的採購。同時，小規模的專業公司和新參與企業則透過在環形態、材料科學和與微創手術的兼容性方面進行針對性創新來展開競爭，並透過有針對性的臨床合作來建立利基市場地位。

為促進推廣應用，提出切實可行的策略建議，包括加強證據收集、建構供應鏈、拓展產品系列以及加強相關人員合作。

產業領導者應採取一系列協同努力，將臨床優勢轉化為永續的商業性優勢。首先，他們應優先投資於比較性臨床證據，以明確柔軟性、剛性或半剛性結構在特定疾病狀態或患者亞群中是否能帶來更優的療效。這些證據應旨在為外科醫生的決策和與支付方的溝通提供基礎。其次，他們應透過供應商多元化、檢驗關鍵零件的近岸替代方案以及實施庫存策略來最佳化供應鏈的韌性，從而減輕貿易政策波動的影響，同時確保品質和合規性。

我們採用穩健的混合方法調查方法，結合臨床醫師的直接見解、文獻綜述、監管審查和相關人員檢驗，以確保分析的可靠性。

本執行摘要依據的研究整合了嚴謹的一手和二手研究，旨在確保其可靠性和相關性。一手數據包括對主要地區的心臟外科醫生、介入性心臟病專家、醫院採購人員和手術室經理進行的結構化訪談，以了解他們的臨床偏好、採購因素和手術流程考慮。此外，我們也與臨床領域意見領袖進行了顧問委員會討論，以檢驗這些訪談對器材設計的影響，並確定證據產生的優先順序。

簡潔扼要的結論概述了設計創新、臨床實踐變革、區域趨勢和供應鏈韌性如何共同塑造策略重點。

總而言之，二尖瓣環環狀成形術環融合了器械工程、不斷發展的外科手術實踐和不斷變化的商業性現實。涵蓋柔軟性、剛性和半剛性器械的設計創新不斷適應成人、老年和兒童患者群體的細微臨床需求，而聚酯、矽膠和鈦等材料的選擇則針對性能和影像相容性進行了最佳化。諸如在複雜心血管手術中推廣綜合方法以及在微創手術中逐步應用等手術趨勢，正在重塑產品要求和臨床證據預期。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依器械類型分類的醫用環狀成形術環市場

  • 柔軟的
    • 二尖瓣
    • 單尖瓣
  • 剛性
    • 圓
    • 馬鞍形狀
  • 半剛性
    • 完整環
    • 開迴路

9. 依手術類型分類的醫用二尖瓣環狀成形術環市場

  • 複雜心血管手術
    • 主動脈瓣置換術
    • 冠狀動脈繞道手術手術
    • 三尖瓣修復
  • 孤立性二尖瓣修復

第10章 依材料類型分類的醫用二尖瓣環狀成形術環市場

  • 聚酯纖維
  • 矽
  • 鈦

第11章 依病患年齡層分類的醫用環狀成形術環市場

  • 成人
  • 老年人
  • 兒童

第12章 依終端使用者管道分類的醫用二尖瓣環狀成形術環市場

  • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院

第13章 區域性醫用環狀成形術環市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫用二尖瓣環狀成形術環市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫用二尖瓣環狀成形術環市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國醫用二尖瓣環狀成形術環市場

第17章：中國醫用二尖瓣環狀成形術環市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Affluent Medical
  • Balton SA
  • BioStable Science & Engineering Ltd.
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardia Innovation AB
  • Cardiac Dimensions, Inc.
  • Colibri Heart Valve, LLC
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Endovalve Inc.
  • Genesee BioMedical
  • Getinge AB
  • Jotec GmbH
  • Labcor Laboratorios Ltda.
  • Lepu Medical Technology Co., Ltd.
  • LivaNova plc
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • Mittentia International
  • NeoChord, Inc.
  • Neovasc Inc.
  • Terumo Corporation
  • Valcare Medical
Product Code: MRR-C36616F6998B

The Medical Mitral Annuloplasty Ring Market was valued at USD 323.45 million in 2025 and is projected to grow to USD 352.32 million in 2026, with a CAGR of 8.89%, reaching USD 587.32 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 323.45 million
Estimated Year [2026] USD 352.32 million
Forecast Year [2032] USD 587.32 million
CAGR (%) 8.89%

A concise authoritative introduction summarizing the evolving role of mitral annuloplasty rings in contemporary cardiac repair and strategic decision-making

Mitral annuloplasty rings occupy a central role in contemporary valvular repair, shaping procedural choices, device innovation, and clinical outcomes across diverse patient populations. Over recent years, iterative improvements in ring design, material science, and implantation techniques have converged to expand therapeutic options for surgeons and cardiologists. As practitioners increasingly favor repair over replacement where clinically appropriate, attention to ring geometry, compliance, and tissue interaction has intensified, prompting manufacturers and clinical teams to re-evaluate device selection frameworks.

Consequently, stakeholders from clinical, regulatory, and commercial domains must understand the interplay between device attributes and clinical pathways. This executive summary synthesizes the most consequential trends, regulatory influences, and channel dynamics influencing annuloplasty use. It is designed for decision-makers seeking concise, actionable perspectives that bridge clinical efficacy and commercial viability. By integrating insights across device type, procedure mix, end-user settings, materials, and patient age groups, the summary supports targeted strategy development and highlights priority areas for investment, collaboration, and evidence generation.

How ongoing design innovations, material advances, procedural shifts, and regulatory expectations are redefining mitral annuloplasty ring development and adoption

The landscape of mitral annuloplasty rings is undergoing several transformative shifts that are reshaping clinical practice and industry priorities. First, device design evolution is moving beyond binary choices between rigid and flexible constructs toward hybrid solutions that aim to balance annular remodeling with physiological motion. Innovations in semi-rigid geometries and saddle-shaped rigid options are changing intraoperative decision-making by offering tailored biomechanical profiles for different pathologies.

Second, material science advances are expanding the palette of implantable substrates. Polyester remains a mainstay for its suturability and tissue integration, while silicone elements and titanium cores are being leveraged to tune stiffness and radiopacity. As a result, device developers are pursuing differentiated value propositions grounded in long-term durability and imaging compatibility. Third, shifts in procedural practice reflect a stronger emphasis on minimally invasive approaches and on integrating annuloplasty into combined cardiac procedures when clinically indicated. These procedural trends increase the demand for rings optimized for different access routes and combined operative workflows. Fourth, regulatory scrutiny and post-market evidence expectations are rising, prompting manufacturers to invest in real-world data collection and robust clinical follow-up. Collectively, these shifts create opportunities for clinical innovation while elevating the importance of cross-functional alignment between engineering, clinical affairs, and commercialization teams.

Analysis of how the 2025 tariff changes in the United States prompted supply chain resilience, sourcing shifts, and commercial adaptations for device manufacturers

Tariff policy changes in the United States during 2025 introduced nuanced headwinds and strategic recalibrations across medical device supply chains that interact with mitral annuloplasty ring availability and pricing dynamics. In practice, heightened import duties on select components and raw materials elevated landed costs, prompting manufacturers to reassess sourcing strategies and inventory policies. In response, firms accelerated nearshoring and diversified supplier networks to mitigate exposure while preserving device quality and compliance with regulatory requirements.

Moreover, these tariff-driven cost pressures influenced commercial tactics, with several companies prioritizing higher-value SKUs, bundling services, and reinforcing clinical value messaging to protect adoption pathways. Hospitals and ambulatory surgical centers faced incremental procurement complexity, which in turn influenced selection algorithms favoring devices with demonstrable procedural efficiency or long-term durability that justify their total procedural cost. Importantly, the tariff environment also catalyzed stronger collaboration between industry and health systems to identify cost-neutral pathways for maintaining patient access, such as optimizing inventory turns and leveraging consignment models. Taken together, policy shifts in 2025 triggered supply chain resilience measures and commercial adaptations that are likely to have sustained influence on sourcing, pricing discipline, and go-to-market prioritization across the sector.

Detailed segmentation-driven insights explaining how device design, procedure context, end-user setting, materials, and patient age influence clinical and commercial strategy

A nuanced segmentation framework reveals distinct clinical and commercial implications across device type, procedure type, end-user channel, material choice, and patient age group. Based on device type, the market is characterized by flexible rings that include bicuspid and monocusp designs, rigid rings that present circular and saddle-shaped geometries, and semi-rigid rings that are available as complete or open designs; each category addresses different mitral pathologies and surgical philosophies and therefore requires targeted evidence packages and surgeon education programs.

Based on procedure type, utilization divides between combined cardiac procedures and isolated mitral valve repair; within combined cardiac procedures, the clinical mix includes aortic valve replacement, coronary artery bypass grafting, and tricuspid valve repair, necessitating devices that integrate cleanly into multi-procedure operative workflows. Based on end user channel, adoption occurs in ambulatory surgical centers and hospitals, and hospitals further split into private and public institutions, where procurement cycles, reimbursement dynamics, and case complexity vary considerably. Based on material type, devices employ polyester, silicone, and titanium to balance suturability, flexibility, and radiopacity, which has implications for manufacturing processes and long-term clinical monitoring. Finally, based on patient age group, clinical considerations differ across adult, geriatric, and pediatric populations, shaping design priorities such as growth accommodation in younger patients and enhanced durability for older cohorts. Together, these segmentation lenses highlight where clinical needs, commercial models, and regulatory strategies must align to achieve differentiated market positioning.

Comparative regional insights highlighting how clinical adoption, regulatory frameworks, and payer dynamics differ across the Americas, EMEA, and Asia-Pacific

Regional dynamics continue to shape clinical practice patterns, regulatory demands, and commercialization approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong procedural volumes, high proceduralization of mitral repair, and an established network of academic centers drive early adoption of innovative ring geometries and materials, while procurement sophistication and payer scrutiny steer manufacturers to emphasize value and long-term outcomes data. Transitionally, the Americas market often acts as a beacon for clinical evidence generation that informs adoption elsewhere.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and reimbursement pathways requires nimble market entry strategies and localized evidence generation. Countries with centralized health systems demand health economic modeling and robust outcome data, whereas regions with private hospital networks may prioritize differentiated surgical efficiency. Meanwhile, Asia-Pacific presents a combination of rapid capacity expansion in tertiary centers, an increasing focus on minimally invasive pathways, and evolving reimbursement constructs that can favor scaled production and cost-effective device variants. Cross-regionally, firms are prioritizing adaptable clinical value stories and region-specific regulatory roadmaps to accelerate adoption across these diverse geographies.

A strategic overview of competitive forces, innovation pathways, and partnership models driving differentiation and clinical uptake in the annuloplasty ring sector

Competitive dynamics in the mitral annuloplasty ring arena are shaped by an interplay of established medtech firms, focused device innovators, specialized contract manufacturers, and clinical-focused start-ups. Market leaders typically leverage broad cardiovascular portfolios, global regulatory footprints, and long-standing clinical relationships to drive surgeon preference and institutional procurement. At the same time, smaller specialist companies and newer entrants often compete through targeted innovation in ring geometry, material science, and minimally invasive compatibility, carving niche positions through focused clinical collaborations.

Strategic partnerships between device designers and clinical centers remain a critical pathway for de-risking early-stage innovation and accelerating evidence generation. Manufacturers are increasingly investing in post-market clinical registries and real-world evidence initiatives to demonstrate comparative performance in diverse patient subgroups. Furthermore, the competitive landscape is influenced by manufacturing scale and supply chain control: organizations that can optimize component sourcing, streamline sterilization logistics, and maintain regulatory compliance without compromising product integrity achieve faster time-to-adoption in key centers. Collectively, these dynamics underscore the need for balanced portfolios that combine flagship products with niche offerings and an emphasis on clinician training and outcomes data to sustain market relevance.

Actionable strategic recommendations for leaders to strengthen evidence, supply chains, product portfolios, and stakeholder partnerships to accelerate adoption

Industry leaders should pursue a coordinated set of actions to convert clinical strength into sustainable commercial advantage. First, prioritize investment in comparative clinical evidence that clarifies when flexible, rigid, or semi-rigid constructs deliver superior outcomes for specific pathologies and patient subgroups; this evidence should be designed to inform surgeon decision-making and payer conversations alike. Second, optimize supply chain resilience by diversifying suppliers, validating nearshore alternatives for critical components, and implementing inventory strategies that reduce the impact of trade policy volatility while preserving quality and compliance.

Third, align product portfolios with end-user workflows by ensuring devices are optimized for hospitals and ambulatory surgical centers, and by developing tailored value propositions for private and public hospital settings. Fourth, emphasize modular commercial models that allow for procedural bundles, training services, and outcome-based contracting where appropriate, thereby linking device selection to demonstrable clinical and operational benefits. Fifth, accelerate material and design R&D focused on imaging compatibility, minimally invasive deployment, and long-term tissue integration, particularly for geriatric and pediatric use cases where clinical demands diverge. Finally, cultivate collaborative relationships with heart teams and key opinion leaders to support guideline inclusion and to drive educational programs that translate device advantages into standardized clinical practice. Together, these steps will help organizations translate technical innovation into durable market advantage.

A robust mixed-methods research approach combining primary clinician insights, literature synthesis, regulatory review, and stakeholder validation to ensure reliable analysis

The research underpinning this executive summary integrates rigorous primary and secondary inquiry designed to ensure robustness and relevance. Primary inputs include structured interviews with cardiac surgeons, interventional cardiologists, hospital procurement leaders, and operating room managers collected across major geographies to capture clinical preferences, procurement drivers, and procedural workflow considerations. These interviews were complemented by advisory board consultations with clinical thought leaders to validate device design implications and to prioritize evidence-generation needs.

Secondary inputs comprise a systematic review of peer-reviewed literature, clinical guidelines, regulatory filings, and public health agency communications to triangulate clinical outcomes, material performance, and safety profiles. Regulatory pathway analyses were assembled from public agency guidance and published conformity assessments, while supply chain and tariff implications were informed by trade policy notices and industry sourcing disclosures. Finally, all qualitative insights were cross-validated through scenario testing with commercial and clinical stakeholders to ensure practical applicability and to identify priority areas for follow-up research. This mixed-methods approach ensures that the analysis remains both clinically grounded and commercially actionable.

A concise conclusion synthesizing how design innovation, clinical practice shifts, regional dynamics, and supply chain resilience collectively shape strategic priorities

In summary, mitral annuloplasty rings stand at the intersection of device engineering, evolving surgical practice, and shifting commercial realities. Design innovation-spanning flexible, rigid, and semi-rigid constructs-continues to align with nuanced clinical needs across adult, geriatric, and pediatric cohorts, while material choices like polyester, silicone, and titanium are being optimized for performance and imaging compatibility. Procedural trends that favor integrated approaches in combined cardiac operations and incremental adoption in minimally invasive settings are reshaping product requirements and clinical evidence expectations.

At the same time, regional heterogeneity in regulatory scrutiny, payer dynamics, and hospital procurement practices necessitates tailored market entry and commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Recent tariff developments have underscored the importance of supply chain agility and commercial adaptability. For stakeholders, the path forward is clear: invest in targeted evidence generation, reinforce resilient sourcing, and align product design with real-world clinical workflows to convert clinical promise into durable clinical and commercial impact. This integrated approach will help the sector deliver improved patient outcomes while navigating the complex dynamics of modern healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Mitral Annuloplasty Ring Market, by Device Type

  • 8.1. Flexible
    • 8.1.1. Bicuspid
    • 8.1.2. Monocusp
  • 8.2. Rigid
    • 8.2.1. Circular
    • 8.2.2. Saddle Shaped
  • 8.3. Semi Rigid
    • 8.3.1. Complete Ring
    • 8.3.2. Open Ring

9. Medical Mitral Annuloplasty Ring Market, by Procedure Type

  • 9.1. Combined Cardiac Procedures
    • 9.1.1. Aortic Valve Replacement
    • 9.1.2. Coronary Artery Bypass Grafting
    • 9.1.3. Tricuspid Valve Repair
  • 9.2. Isolated Mitral Valve Repair

10. Medical Mitral Annuloplasty Ring Market, by Material Type

  • 10.1. Polyester
  • 10.2. Silicone
  • 10.3. Titanium

11. Medical Mitral Annuloplasty Ring Market, by Patient Age Group

  • 11.1. Adult
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Medical Mitral Annuloplasty Ring Market, by End User Channel

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
    • 12.2.1. Private Hospitals
    • 12.2.2. Public Hospitals

13. Medical Mitral Annuloplasty Ring Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Mitral Annuloplasty Ring Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Mitral Annuloplasty Ring Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Mitral Annuloplasty Ring Market

17. China Medical Mitral Annuloplasty Ring Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Affluent Medical
  • 18.7. Balton S.A.
  • 18.8. BioStable Science & Engineering Ltd.
  • 18.9. Boston Scientific Corporation
  • 18.10. Braile Biomedica
  • 18.11. Cardia Innovation AB
  • 18.12. Cardiac Dimensions, Inc.
  • 18.13. Colibri Heart Valve, LLC
  • 18.14. CryoLife, Inc.
  • 18.15. Edwards Lifesciences Corporation
  • 18.16. Endovalve Inc.
  • 18.17. Genesee BioMedical
  • 18.18. Getinge AB
  • 18.19. Jotec GmbH
  • 18.20. Labcor Laboratorios Ltda.
  • 18.21. Lepu Medical Technology Co., Ltd.
  • 18.22. LivaNova plc
  • 18.23. Medtronic plc
  • 18.24. Micro Interventional Devices, Inc.
  • 18.25. Mittentia International
  • 18.26. NeoChord, Inc.
  • 18.27. Neovasc Inc.
  • 18.28. Terumo Corporation
  • 18.29. Valcare Medical

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY BICUSPID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY BICUSPID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY BICUSPID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MONOCUSP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MONOCUSP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MONOCUSP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CIRCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CIRCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CIRCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SADDLE SHAPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SADDLE SHAPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SADDLE SHAPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY OPEN RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY OPEN RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY OPEN RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AORTIC VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AORTIC VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AORTIC VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ISOLATED MITRAL VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ISOLATED MITRAL VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ISOLATED MITRAL VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 189. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 190. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. NATO MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY SEMI RIGID, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY COMBINED CARDIAC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY END USER CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA MEDICAL MITRAL ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)